Abstract
Impact of SYNTAX score (SS) on long-term clinical outcomes after new-generation drug-eluting stents implantation for unprotected left main disease remains unclear. Between February 2010 and July 2012, 2,519 consecutive patients with 3,410 lesions were treated only with new-generation drug-eluting
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
